Phase i/ii study of docetaxel (DOC) and carboplatin (CBDCA) with concurrent radiotherapy in patients with stage III unresectable non-small cell lung cancer (NSCLC), preliminary results

2001 ◽  
Vol 37 ◽  
pp. S56
Author(s):  
S. Kato ◽  
M. Sakura ◽  
T. Kazumoto ◽  
H. Sakai ◽  
S. Yoneda ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Phase I ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Small Cell ◽  
Stage Iii ◽  
Small Cell Lung ◽  
Preliminary Results ◽  
Concurrent Radiotherapy

Phase I trial of carboplatin/paclitaxel/bortezomib and concurrent radiotherapy followed by surgical resection in Stage III non-small cell lung cancer

Lung Cancer ◽  
2010 ◽  
Vol 68 (1) ◽  
pp. 84-88 ◽  
Author(s):  
Martin J. Edelman ◽  
Whitney Burrows ◽  
Mark J. Krasna ◽  
Michelle Bedor ◽  
Ruth Smith ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Phase I ◽  
Small Cell Lung Cancer ◽  
Surgical Resection ◽  
Cell Lung Cancer ◽  
Phase I Trial ◽  
Small Cell ◽  
Stage Iii ◽  
Small Cell Lung ◽  
Concurrent Radiotherapy

Phase I/II study of carboplatin plus nab-paclitaxel and concurrent radiotherapy for patients with locally advanced non–small cell lung cancer

Lung Cancer ◽  
2018 ◽  
Vol 125 ◽  
pp. 136-141 ◽  
Author(s):  
Yuko Kawano ◽  
Tomonari Sasaki ◽  
Hiroyuki Yamaguchi ◽  
Katsuya Hirano ◽  
Atsushi Horiike ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Phase I ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Locally Advanced ◽  
Small Cell ◽  
Small Cell Lung ◽  
Concurrent Radiotherapy
Sign in / Sign up

Export Citation Format

Share Document